MORIAH DAVIS: Open Payments
NPI 1568013415 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,957 in 113 payments from 16 companies in 2025. Trend: 2023 $166 · 2024 $541 · 2025 $2,957
Food & beverage: $2,716Education: $240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $520 |
| Regeneron Healthcare Solutions, Inc. | 7 | $399 |
| Janssen Biotech, Inc. | 10 | $351 |
| UCB, Inc. | 16 | $316 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $283 |
| PFIZER INC. | 6 | $237 |
| E.R. Squibb & Sons, L.L.C. | 7 | $170 |
| Arcutis Biotherapeutics, Inc. | 5 | $167 |
| Novartis Pharmaceuticals Corporation | 6 | $127 |
| GENZYME CORPORATION | 3 | $91 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, Sotyktu, Zoryve, RINVOQ, LITFULO.
Industry payments across NY — which companies pay providers there.
